Cubriva^®

Therapeutic Segment:
Anti-epileptic

Generic Name:
Brivaracetam

Description:
Brivaracetam displays a high and selective affinity for synaptic vesicle protein 2A (SV2A) in the brain, which may contribute to the anti-convulsant effect.

Indication:
Brivaracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older.

Formulation:

• Tablets
• Oral Solution
• Injection

Strength:

• Tablets : 25mg, 50mg, 75mg, 100mg
• Oral Solution : 10mg/ml
• Injection : 10mg/ml

Pack Size:

• Tablets : 14’s
• Oral Solution : 60ml
• Injection : 1’s